Cargando…
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
BACKGROUND: Age and comorbidities increase COVID-19 related in-hospital mortality risk, but the extent by which comorbidities mediate the impact of age remains unknown. METHODS: In this multicenter retrospective cohort study with data from 45 Dutch hospitals, 4806 proven COVID-19 patients hospitaliz...
Autores principales: | Henkens, M. T. H. M., Raafs, A. G., Verdonschot, J. A. J., Linschoten, M., van Smeden, M., Wang, P., van der Hooft, B. H. M., Tieleman, R., Janssen, M. L. F., ter Bekke, R. M. A., Hazebroek, M. R., van der Horst, I. C. C., Asselbergs, F. W., Magdelijns, F. J. H., Heymans, S. R. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897728/ https://www.ncbi.nlm.nih.gov/pubmed/35247983 http://dx.doi.org/10.1186/s12877-021-02673-1 |
Ejemplares similares
-
Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
por: Sikking, Maurits A., et al.
Publicado: (2023) -
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022) -
Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study
por: Raafs, Anne G., et al.
Publicado: (2023) -
Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial
por: Hazebroek, Mark R., et al.
Publicado: (2021) -
Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Linschoten, Marijke, et al.
Publicado: (2021)